Virus-Like Particle Vaccine Development

A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Attenuated/Inactivated/Live and Vectored Vaccines".

Deadline for manuscript submissions: 28 February 2025 | Viewed by 148

Special Issue Editor

Biology and Information Science Laboratory, East China Normal University, Shanghai 200050, China
Interests: protein production; virology; vaccine; virus-like particle; liposome; experimental evolution
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Viruses are now recognized as important resources for studying diseases and producing recombinant proteins. Virus-like particles (VLPs), which imitate viruses but do not possess genetic material, are a safe and powerful tool for vaccine development. There has already been some licensed VLP vaccines available in the commercial market against various infectious pathogens. While VLP subunit vaccines have succeeded, there are still challenges to overcome before the VLP surface display system can be widely employed as an effective vaccine strategy for many infectious diseases.

This Special Issue highlights how the leading researchers design, produce, and approve their VLP vaccines using diverse protein expression systems. We also share various perspectives and discuss the future of the VLP-based vaccine strategy.

Dr. Jian Xu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • vaccine
  • virus-like particle
  • display
  • protein production
  • immunogenicity

Published Papers

This special issue is now open for submission.
Back to TopTop